Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinocom Pharmaceutical is a specialty pharmaceutical company based in Hong Kong with a strong operational presence in mainland China. The company focuses on the development, manufacturing, and distribution of small molecule pharmaceutical products, particularly targeting cardiovascular, gastrointestinal, and central nervous system indications. Sinocom serves as a strategic partner for international pharmaceutical firms, providing a comprehensive platform for market entry and distribution within the complex Chinese healthcare landscape. Its manufacturing operations adhere to Good Manufacturing Practice (GMP) standards, producing a diverse portfolio of generic and specialty medications. The company is known for its expertise in formulation development and its robust supply chain for active pharmaceutical ingredients (APIs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinocom Pharmaceutical.